Neuren Pharmaceuticals Ltd (NEU) — Cash Flow Reinvestment Rate
Neuren Pharmaceuticals Ltd (NEU) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting AU$5.00K (capex AU$5.00K ) from operating cash flow of AU$128.31 Million. Check earnings quality score of Neuren Pharmaceuticals Ltd to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Neuren Pharmaceuticals Ltd Cash Flow Reinvestment Rate (2018–2023)
Historical reinvestment intensity for Neuren Pharmaceuticals Ltd across 3 annual periods. Explore NEU long-term investments to assets to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Neuren Pharmaceuticals Ltd (2018–2023)
Year-by-year capital reinvestment analysis for Neuren Pharmaceuticals Ltd. For live market cap and broader valuation context, see how much is Neuren Pharmaceuticals Ltd worth.
| Year | Reinvestment Rate | Total Reinvested (AUD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 1.14x | AU$211.53 Million | AU$184.93 Million | AU$40.00K | ▲ +10733.4% |
| 2022 | 0.01x | AU$38.00K | AU$3.60 Million | AU$19.00K | ▲ +463.8% |
| 2018 | 0.00x | AU$12.00K | AU$6.41 Million | AU$12.00K | — |